saplin

Mirae Asset Healthcare Fund

Mirae Asset Healthcare Fund (Direct, Growth): saplin Score 8.5/10 (Strong) among 126 Sectoral/Thematic funds. 3Y return 24.5% a year vs 14.7% category median, expense ratio 0.59%. Returns that beat most peers, but a short or weak manager record. NAV ₹55.40 on 11 Nov 2026.

Loading the full analysis…

Questions about Mirae Asset Healthcare Fund

What is the expense ratio of Mirae Asset Healthcare Fund?

The Direct plan's total expense ratio is 0.59% a year, against a median of 1.20% for sectoral/thematic funds. The Regular plan costs more because it pays a distributor's commission.

Who manages Mirae Asset Healthcare Fund?

Vishal Singh (since 7 Oct 2026); Sudip Shere (since 7 Oct 2026).

What are the top holdings of Mirae Asset Healthcare Fund?

Sun Pharmaceutical Industries 10.32%, Divi's Laboratories 9.97%, Torrent Pharmaceuticals 6.41%, Laurus Labs 6.37%, Apollo Hospitals Enterprise 5.81% of the portfolio, as of 31 Oct 2026.

What returns has Mirae Asset Healthcare Fund given?

1 year: 28.6% (category median 4.6%); 3 years: 24.5% a year (category median 14.7%); 5 years: 18.1% a year (category median 12.1%). Past returns do not predict future ones.

How big is Mirae Asset Healthcare Fund?

About ₹3,458 cr (AMFI's average for the latest quarter).

How does Mirae Asset Healthcare Fund score?

8.5 out of 10 (Strong) on the saplin Score, which rates a fund against its own category on returns, risk, consistency, cost and its manager. See the methodology for how it is worked out.

More on Mirae Asset Healthcare